These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32626499)

  • 1. Calcium l-methylfolate as a source of folate added for nutritional purposes to infant and follow-on formula, baby food and processed cereal-based food.
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Engel KH; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Sanz Y; Schlatter JR; van Loveren H; Bernasconi G; Germini A; Knutsen HK
    EFSA J; 2020 Jan; 18(1):e05947. PubMed ID: 32626499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of monosodium salt of l-5-methyltetrahydrofolic acid as a novel food pursuant to Regulation (EU) 2015/2283 and the bioavailability of folate from this source in the context of Directive 2002/46/EC, Regulation (EU) No 609/2013 and Regulation (EC) No 1925/2006.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aguilera-Gómez M; Cubadda F; Frenzel T; Heinonen M; Maradona MP; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; Siskos A; van Loveren H; Matijević L; Knutsen HK
    EFSA J; 2023 Nov; 21(11):e8417. PubMed ID: 38035146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of calcium-l-methylfolate and (6S)-5-methyltetrahydrofolic acid glucosamine salt into dietary folate equivalents.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Peláez C; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Abrahantes JC; Dumas C; Ercolano V; Titz A; Pentieva K
    EFSA J; 2022 Aug; 20(8):e07452. PubMed ID: 36034319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of whey basic protein isolate for extended uses in foods for special medical purposes and food supplements for infants pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Engel KH; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Pöting A; Poulsen M; Sanz Y; Schlatter JR; van Loveren H; Amundsen M; Knutsen HK
    EFSA J; 2019 Apr; 17(4):e05659. PubMed ID: 32626285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of cellobiose as a novel food pursuant to regulation (EU) 2015/2283.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Albert O; Knutsen HK
    EFSA J; 2022 Nov; 20(11):e07596. PubMed ID: 36381122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of magnesium l-threonate as a novel food pursuant to regulation (EU) 2015/2283 and bioavailability of magnesium from this source in the context of Directive 2002/46/EC.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aguilera-Gómez M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Maradona MP; Schlatter JR; Siskos A; van Loveren H; Gelbmann W; Knutsen HK
    EFSA J; 2024 Mar; 22(3):e8656. PubMed ID: 38481468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of bovine milk osteopontin as a Novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Maradona MP; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Gelbmann W; Knutsen HK
    EFSA J; 2022 May; 20(5):e07137. PubMed ID: 35572202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of 3-fucosyllactose (3-FL) produced by a derivative strain of
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; van Loveren H; Colombo P; Noriega Fernández E; Knutsen HK
    EFSA J; 2022 May; 20(5):e07329. PubMed ID: 35646167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Maradona MP; Schlatter JR; van Loveren H; Colombo P; Knutsen HK
    EFSA J; 2021 Jun; 19(6):e06662. PubMed ID: 34221147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of 3'-sialyllactose (3'-SL) sodium salt produced by derivative strains of
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; van Loveren H; Colombo P; Noriega Fernández E; Knutsen HK
    EFSA J; 2022 May; 20(5):e07331. PubMed ID: 35646166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Whey basic protein isolates as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Schlatter JR; Amundsen M; van Loveren H
    EFSA J; 2018 Jul; 16(7):e05360. PubMed ID: 32625992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of 6'-Sialyllactose (6'-SL) sodium salt as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Engel KH; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Colombo P; Knutsen HK
    EFSA J; 2020 May; 18(5):e06097. PubMed ID: 37649501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Engel KH; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Pöting A; Poulsen M; Sanz Y; Schlatter JR; van Loveren H; Sun Q; Turla E; Knutsen HK
    EFSA J; 2019 Jun; 17(6):e05717. PubMed ID: 32626339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific opinion on the evaluation of authorised ferric sodium EDTA as an ingredient in the context of Regulation (EC) 258/97 on novel foods and Regulation (EU) 609/2013 on food intended for infants and young children, food for special medical purposes and total diet replacement for weight control.
    ; Younes M; Aggett P; Aguilar F; Crebelli R; Dusemund B; Filipič M; Frutos MJ; Galtier P; Gundert-Remy U; Kuhnle GG; Lambré C; Leblanc JC; Lillegaard IT; Moldeus P; Mortensen A; Oskarsson A; Stankovic I; Waalkens-Berendsen I; Woutersen RA; Wright M; Tobback P; Mcardle H; Germini A; Gott D
    EFSA J; 2018 Aug; 16(8):e05369. PubMed ID: 32626017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extension of use of isomalto-oligosaccharide as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aguilera-Gómez M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; Siskos A; van Loveren H; Albert O; Knutsen HK
    EFSA J; 2024 Feb; 22(2):e8543. PubMed ID: 38322231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of 6'-sialyllactose (6'-SL) sodium salt produced by derivative strains of
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Prieto Maradona M; Schlatter JR; van Loveren H; Colombo P; Noriega Fernández E; Knutsen HK
    EFSA J; 2022 Dec; 20(12):e07645. PubMed ID: 36507098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of iron milk proteinate as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of iron from this source in the context of Directive 2002/46/EC.
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Ackerl R; Knutsen HK
    EFSA J; 2022 Sep; 20(9):e07549. PubMed ID: 36177390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of lacto-N-fucopentaose I/2'-fucosyllactose (LNFP-I/2'-FL) mixture as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aguilera-Gómez M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Peláez C; Poulsen M; Schlatter JR; Siskos A; van Loveren H; Colombo P; Noriega Fernández E; Knutsen HK
    EFSA J; 2023 Dec; 21(12):e8412. PubMed ID: 38046202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of 3'-Sialyllactose (3'-SL) sodium salt as a novel food pursuant to Regulation (EU) 2015/2283.
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Engel KH; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Colombo P; Knutsen HK
    EFSA J; 2020 May; 18(5):e06098. PubMed ID: 37649513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.